Bioventus Inc. (BVS)
Medical - Devices · Healthcare · $611M
Intrinsic Value (Consensus)
$7.68
Current Price
$8.73
Margin of Safety
-12%
12% Above Intrinsic Value
Value: $8
Price: $9
Valuation Model Estimates
Current Price: $8.73
DCF (Discounted Cash Flow)
$16.46
Graham Number
$4.45
Earnings Power Value
$3.20
Relative Value (P/E)
$6.60
Dividend Discount Model
Not applicable
—
Consensus Value
$7.68
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
50
Profitability
18/25
Strength
16/25
Valuation
12/25
Growth
4/25
Financial Health Signals
Elevated debt — Debt/Equity ratio is 194%
Declining revenue — top line is shrinking
High free cash flow yield (11.8%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $0.33
- EPS (Forward)
- $0.35
- Book Value
- $2.67
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 12.3%
- Debt/Equity
- 194%
- Revenue Growth
- -0.9%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 0.67
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance